S 6746

  • New York Senate Bill
  • 2021 Regular Session
  • Introduced in Senate
  • Passed Senate May 25, 2022
  • Assembly
  • Governor

Relates to the availability of buprenorphine in opioid treatment programs

Abstract

Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.

Bill Sponsors (2)

Votes


Actions


May 25, 2022

Assembly

REFERRED TO WAYS AND MEANS

Senate

DELIVERED TO ASSEMBLY

Senate

PASSED SENATE

May 11, 2022

Senate

ADVANCED TO THIRD READING

May 10, 2022

Senate

2ND REPORT CAL.

May 09, 2022

Senate

1ST REPORT CAL.1092

Apr 27, 2022

Senate

PRINT NUMBER 6746A

Senate

AMEND AND RECOMMIT TO ALCOHOLISM AND SUBSTANCE ABUSE

Jan 05, 2022

Senate

REFERRED TO ALCOHOLISM AND SUBSTANCE ABUSE

May 13, 2021

Senate

REFERRED TO ALCOHOLISM AND SUBSTANCE ABUSE

Bill Text

Bill Text Versions Format
S6746 PDF HTML
S6746A PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.